EUVIMEDEUVIMED entdecken
Crossref

An adaptive design for optimizing treatment assignment in randomized clinical trials

Wei Zhang iD, Zhiwei Zhang iD, Aiyi Liu iD

Biometrics · 2026

DOI: 10.1093/biomtc/ujaf168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrics, 2026. Verfasst von Wei Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Mathematical Sciences, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, China. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design, Models, Statistical. Die Arbeit nennt 17 Literaturangaben. Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment assignment mechanism in a randomized clinical trial can be optimized for statistical efficiency within a specified class of randomization mechanisms. Optimal designs of this type have been characterized in terms of the variances of potential outcomes conditional on baseline covariates. Approximating these optimal designs requires information about the conditional variance functions, which is often unavailable or unreliable at the design stage. As a practical solution to this dilemma, we propose a multi-stage adaptive design that allows the treatment assignment mechanism to be modified at interim analyses based on accruing information about the conditional variance functions. This adaptation has profound implications on the distribution of trial data, which need to be accounted for in treatment effect estimation. We consider a class of treatment effect estimators that are consistent and asymptotically normal, identify the most efficient estimator within this class, and approximate the most efficient estimator by substituting estimates of unknown quantities. Simulation results indicate that, when there is little or no prior information available, the proposed design can bring substantial efficiency gains over conventional one-stage designs based on the same prior information. The methodology is illustrated with real data from a completed trial in stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignModels, StatisticalComputer SimulationHumansStrokeData Interpretation, StatisticalBiometryTreatment Outcome

Stichwörter der Autor:innen

augmentationcovariate adjustmentinterim analysisoptimal designpropensity scoretreatment allocation

Autor:innen und Institutionen

  • State Key Laboratory of Mathematical Sciences, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, China.
  • Biostatistics Innovation Group, Gilead Sciences, Foster City, CA 94404, United States.
  • Biostatistics and Bioinformatics Branch, Division of Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20817, United…

ORCID-Profile: Wei Zhang, Zhiwei Zhang, Aiyi Liu

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Zhang, W., Zhang, Z., & Liu, A. (2026). An adaptive design for optimizing treatment assignment in randomized clinical trials. Biometrics. https://doi.org/10.1093/biomtc/ujaf168

Vancouver

Zhang W, Zhang Z, Liu A. An adaptive design for optimizing treatment assignment in randomized clinical trials. Biometrics. 2026. doi:10.1093/biomtc/ujaf168

BibTeX
@article{Zhang2026,
  author = {Zhang, Wei and Zhang, Zhiwei and Liu, Aiyi},
  title = {An adaptive design for optimizing treatment assignment in randomized clinical trials},
  journal = {Biometrics},
  year = {2026},
  doi = {10.1093/biomtc/ujaf168}
}
Kostenlos starten →